2015-09-09T07:42:08-07:00 2014-12-31 FRITZ DEGUGLIELMO LLC 8 ESSEX STREET NEWBURYPORT MA 01950 990 2014-01-01 462266526 Lifebox Foundation Inc LIFE 6173845455 PO Box 15342 Boston MA 02215 ATUL GAWANDE PRESIDENT 6173845455 2015-07-31 true STEPHEN J DEGUGLIELMO CPA 9784622161 2015-09-09 2014 2016-02-25 16:41:14Z ATUL GAWANDE PO Box 15342 Boston MA 02215 319699 false X www.lifeboxusa.org X 2013 MA To improve the safety of healthcare in low and middle-income countries. 6 6 0 8 0 44349 304619 15080 0 0 44349 319699 0 0 0 0 14949 15 159448 15 159448 44334 160251 44334 204585 0 44334 204585 To improve the safety of healthcare false false 81000 181000 TO PRESERVE AND PROTECT THE HEALTH OF PATIENTS WORLDWIDE BY PROVIDING PULSE OXIMETERS AND TRAINING TO HOSPITALS AND HEALTHCARE FACILITIES IN LOW AND MIDDLE-INCOME COUNTRIES. 13578 15080 TO ENCOURAGE AND FACILITATE RESEARCH OF UNSAFE HEALTHCARE AND PATIENT SAFETY. 29947 TO EDUCATE THE PUBLIC ON THE INCREASINGLY IMPORTANT ROLE OF SURGERY AND ANESTHESIA WITHIN GLOBAL HEALTHCARE. 124525 true true false false false false false false false false false false false false false true false false false false true false false false false false false false false false false false false false false false false true false false false false false false false false false true 0 0 0 false false false false false false false false false false X 6 6 true false true false false false false true true false false true true true true false false false false false MA X KIT NICHOLS 6173845455 PO Box 15342 Boston MA 02215 X WILLIAM BERRY MD Director 1.00 X 0 0 0 DEBORAH LOTTERMAN Director 1.00 X 0 0 0 THOMAS WEISER MD Director 1.00 X 0 0 0 ATUL GAWANDE MD President 1.00 X X 0 0 0 ALEXANDER HANNENBERG MD Secretary 1.00 X X 0 0 0 JASON YEUNG Treasurer 1.00 X X 0 0 0 false false false 304619 14691 304619 Safe surgery program 813212 15080 15080 319699 15080 30768 10256 10256 10256 950 0 950 0 8458 1421 7037 0 18270 18270 0 0 1391 0 1391 0 Safe surgery program expense 13578 13578 0 0 Pulse oximeter program expense 81000 81000 0 0 Dues and subscriptions 340 0 340 0 Fundraising expense 4693 0 0 4693 159448 124525 19974 14949 44334 204585 44334 204585 0 0 X 44334 104585 100000 44334 204585 44334 204585 160251 X true X false false false X 0 0 0 44349 304619 348968 15080 15080 44349 319699 364048 245691 245691 245691 245691 118357 364048 X 0 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X Pt X, Line 2 The Organization has adopted the application of the provisions of FASB ASC 740-10 (formerly FASB Interpretation No. 48, "Accounting For Uncertainty in Income"). The primary tax positions made by the Organization are the existence of Unrelated Business Income Tax and the Organization's status as an exempt organization under Section 501(c)(3) of the Internal Revenue Code. The Organization currently evaluates all tax positions, and makes determinations regarding the likelihood of those positions being upheld under review. For the years presented, and as a result of adoption, the Organization has not recognized any tax benefits or loss contingencies for uncertain tax positions based on its evaluations. The Organization's Forms 990, Return of Organization Exempt from Income Tax, for the years ending December 31, 2014 and 2013, the Organization's first year of operations, are subject to examination by the IRS, generally for 3 years after they are filed. true Europe 0 0 Program services Safe surgery program - training 13578 Sub-Saharan Africa 0 0 Program services Pulse oximeters & training 81000 0 0 0 0 94578 94578 false false false false false false Pt I Line 2 The Organization monitors the use of its international funding through reporting and direct observation. Pt I Line 3 Col (F) Accounting method - cash, all amounts reported are expenditures. Ariadne Labs See supplemental 15080 See supplemental false Ariadne Labs See supplemental 30768 See supplemental false Part IV, (1) The president and another member of the Organization's board of directors are Ariadne Labs' executive director and chief medical officer, respectively. During 2014, Ariadne Labs paid the Organization $15,080 under a consulting agreement to provide services under the Organization's Safe Surgery Program in Moldova. Part IV, (2) The president and another member of the Organization's board of directors are Ariadne Labs' executive director and chief medical officer, respectively. During 2014, the Organization paid Ariadne Labs $30,768 for work performed by the Organization's Director of Operations, who is an employee of Ariadne Labs. Pt VI, Line 19 The Organization's governing documents, conflict of interest policy, and financial statements are available to the public upon request. Pt VI, Line 11b The Organization's Director of Operations reviews the form 990 and compare it to the financial statements. The board then reviews and approves the form 990. Pt VI, Line 12c Compliance with the conflict of interest policy is monitored by board members being required to review the policy and their interests on an annual basis. Pt VI, Line 2 The Organization's president is the executive director of another organization of which another member of the Organization's board of directors is the Chief Medical Officer and the Organization's director of operations is employed. Pt VI, Line 4 During 2014, the Organization amended its by-laws to increase the maximum number of allowable board members from 5 to 12 and to increase the terms of the board members from 1 to 2 years.